DW-166HC

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameDW-166HC
Drug Alias NameHolmium 166 chitosan166 holmium poliglusam166 holmium chitosan complexHolmium-166-Chitosan complexMilican +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIonising radiation emitters
TargetsNot applicable
Therapy Area/IndicationsHemophilia ASkin NeoplasmsCarcinoma, Hepatocellular
Global Approved IndicationsHemophilia ASkin NeoplasmsCarcinoma, Hepatocellular
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date2001/01/01
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesDong Wha Pharm Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDong Wha Pharm Co Ltd
Inactive CompaniesN/A
Active IndicationsHemophilia ASkin NeoplasmsCarcinoma, Hepatocellular
Inactive IndicationsN/A

Other Information

ATC CodeV10
Related LinksN/A